Helicobacter pyloriand NSAID-Associated Ulcers

Gheng, Michael W.; Barkin, Jamie S.
February 2004
American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p397
Academic Journal
Labenz J, Blum AL, Bolten WW, et al.Primary Prevention of Diclofenac Associated Ulcers and Dyspepsia by Omeprazole or Triple Therapy in Helicobacter pylori Positive Patients: A Randomised, Double Blind, Placebo Controlled, Clinical Trial Gut 2002;51:329–335


Related Articles

  • Study of Outcome After Targeted Intervention for Peptic Ulcer Resistant to Acid Suppression Therapy. Lanas, Angel; Remacha, Begoña; Sáinz, Ricardo; Hirschowitz, Basil I. // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p513 

    OBJECTIVE: Different factors might affect outcome in ulcers resistant to antisecretory therapy. The aim of the study was to define the odds of resistant ulcers being associated with NSAID use, and/or Helicobacter pylori (H. pylori) infection, or neither. METHODS: A total of 80 patients...

  • Omeprazole, the Victor! Young, R. L.; Thompson, Jon S. // American Journal of Gastroenterology;Aug1998, Vol. 93 Issue 8, p1200 

    Discusses research being done on the comparison between ranitidine and omeprazole, and misoprostol and omeprazole for non-steroidal anti-inflammatory drug (NSAID)-associated ulcer treatment. Investigation on the efficacy of omeprazole and ranitidine in patients with gastroduodenal ulcers and...

  • Serologic testing is more cost-effective strategy for ulcer symptoms.  // Geriatrics;Oct95, Vol. 50 Issue 10, p16 

    Reports that antibiotic therapy following a positive serology for Helicobacter pylori appears to be the most cost-effective approach in treating patients with symptoms of peptic ulcers. Non-application of the strategy to treating peptic ulcer symptoms caused by chronic use of non-steroidal...

  • OMEPRAZOLE FOR BLEEDING PUD: DO WE FINALLY HAVE EVIDENCE FOR EFFECTIVE MEDICAL THERAPY? Pedersen, Peder J.; Bjorkman, David J.; Johnson, David // American Journal of Gastroenterology;Sep1998, Vol. 93 Issue 9, p1583 

    Khuroo et al. recently reported a prospective randomized trial comparing oral omeprazole with placebo as therapy for bleeding peptic ulcer disease. Of 869 patients evaluated at a single center for upper gastrointestinal bleeding, 220 were found at early endoscopy to have an ulcer with...

  • Omeprazole: A Review of its Use in Helicobacter pylori Infection, Gastro-Oesophageal Reflux Disease and Peptic Ulcers Induced by Nonsteroidal Anti-Inflammatory Drugs. Langtry, H.D.; Wilde, M.I. // Drugs;Sep1998, Vol. 56 Issue 3, p447 

    Omeprazole is a well studied proton pump inhibitor that reduces gastric acid secretion. This review examines its use in Helicobacter pylori infection, gastro-oesophageal reflux disease (GORD) with or without oesophagitis and gastrointestinal damage caused by nonsteroidal anti-inflammatory drugs...

  • Evaluation and Management of Patients With Recurrent Peptic Ulcer Disease After Acid-Reducing Operations: A Systematic Review Turnage, Richard H.; Sarosi, George; Cryer, Byron; Spechler, Stuart; Peterson, Walter; Feldman, Mark // Journal of Gastrointestinal Surgery;Jul2003, Vol. 7 Issue 5, p606 

    This systematic review examines the evidence for commonly employed strategies of managing patients with recurrent ulcer disease after acid-reducing operations. Particular attention is given to recent evidence relating Helicobacter pylori (H. pylori ) and nonsteroidal anti-inflammatory drugs...

  • ERADICATE THE BUG BEFORE YOU START THE DRUG? Metz, David C.; Johnson, David // American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p279 

    Presents a commentary about a randomized trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug (NSAID) therapy to prevent peptic ulcers. Evaluation and treatment of patients with nonulcer dyspepsia; Controversy regarding strategies for primary prevention of...

  • Peptic Ulcer Disease. Ramakrishnan, Kalyanakrishnan; Salinas, Robert C. // American Family Physician;10/1/2007, Vol. 76 Issue 7, p1005 

    Peptic ulcer disease usually occurs in the stomach and proximal duodenum. The predominant causes in the United States are infection with Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs. Symptoms of peptic ulcer disease include epigastric discomfort (specifically, pain...

  • NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Chan, Francis K.L. // Drug Safety;2005, Vol. 28 Issue 4, p287 

    The conflicting data about the influence of Helicobacter pylori infection on the ulcer risk in patients receiving NSAIDs can be accounted for by the heterogeneity of study designs and the diversified host response to H. pylori. Factors that will affect the outcome include the choice of H. pylori...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics